
|Articles|October 24, 2022
Calyx Expands IRT System
IRT system enhanced with new self-service functionality.
Advertisement
Calyx announced an enhancement to its interactive response technology (IRT) system. The eClinical services provider has expanded its self-service IRT tools, which enable clinical trial sponsors and CROs to adapt to trial needs without reprogramming.
Read more about the system enhacements
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
2
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
3
FDA Approves Caplyta as Adjunctive Therapy for Major Depressive Disorder Based on Positive Phase III Results
4
ACT Brief: Designing Feasible Protocols and Breakthroughs in Obesity and Metabolic Research
5






.png)



.png)



.png)
.png)
